Elevance Health is standing by its forecast for 2024, projecting a net income of over $34.29 per diluted share and...

On March 2, 2024, analyst Chris Parkinson from Wolfe Research began analyzing Element Solutions (NYSE: ESI) and gave it a...

Annexon's stock is on the rise following a significant upgrade by JP Morgan on March 2, 2024. The upgrade from...

On March 2, 2024, Wells Fargo analyst Roger Read reiterated his positive stance on Chart Industries (NYSE: GTLS), upgrading the...

On March 2, 2024, analyst Simeon Gutman of Morgan Stanley reiterated an Equal-Weight rating for Best Buy Co (NYSE: BBY)...

Baird analyst Shrenik Kothari remains bullish on Zscaler (NASDAQ: ZS) with an Outperform rating and a revised price target of...

On March 2, 2024, Stephen Byrd, an analyst at Morgan Stanley, reiterated his Equal-Weight rating on Clearway Energy (NYSE:CWEN) and...

On March 2, 2024, analyst Benjamin Hartford from Baird maintained a Neutral rating on Forward Air (NASDAQ:FWRD) but lowered the...

Analyst Geoff Meacham from B of A Securities is optimistic about Eli Lilly and Co (NYSE:LLY), maintaining a Buy rating...

Wolfe Research analyst Chris Parkinson has recently started covering Corteva (NYSE: CTVA) with an Outperform rating. This analysis was initiated...